The Indiana Board of Pharmacy agreed to revoke the New England Compounding Center’s license for its connection to the meningitis outbreak.

The Massachusetts-based pharmacy reached a voluntary agreement last Friday with Indiana Attorney General Greg Zoeller’s office. The board then approved the agreement today.

“Public health and safety is a top priority and today’s action was a necessary step to ensure this company, which put patients unnecessarily at risk, does not operate within our state’s borders going forward,” Zoeller said.

Zoeller said a license revocation means the company cannot operate in Indiana for at least seven years. The company could apply for a new license after that time, but the board would have to approve the license application.

As of Feb. 4th the U.S. Centers for Disease Control reported 10 deaths and 79 total cases of fungal meningitis in Indiana stemming from bad steroid injections produced by NECC.

Nationwide there were a total of 696 cases and 45 deaths across 20 states.